Evidence map›Paper›PMID 39448590›Full record

ArticleNature communications2024

Selective RNA pseudouridinylation in situ by circular gRNAs in designer organelles.

Lukas Schartel, Cosimo Jann, Anna Wierczeiko, Tamer Butto, Stefan Mündnich, Virginie Marchand, Yuri Motorin, Mark Helm, Susanne Gerber, Edward A Lemke

Abstract read
In one paragraph

Article in Nature communications, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Lukas SchartelBiocenter, Johannes Gutenberg University, Mainz, Germany.
Cosimo JannBiocenter, Johannes Gutenberg University, Mainz, Germany.
Anna WierczeikoInstitute of Human Genetics, University Medical Center of the Johannes Gutenberg University, Mainz, Germany.ORCID 0000-0003-0684-926X
Tamer ButtoInstitute of Pharmaceutical and Biomedical Sciences, Johannes Gutenberg-University Mainz, Mainz, Germany.
Stefan MündnichInstitute of Pharmaceutical and Biomedical Sciences, Johannes Gutenberg-University Mainz, Mainz, Germany.
Virginie MarchandUniversité de Lorraine CNRS, INSERM, UAR2008/US40 IBSLor, EpiRNA-Seq Core Facility, Nancy, France.
Yuri MotorinUniversité de Lorraine CNRS, UMR7365 IMoPA, Nancy, France.
Mark HelmInstitute of Pharmaceutical and Biomedical Sciences, Johannes Gutenberg-University Mainz, Mainz, Germany.ORCID 0000-0002-0154-0928
Susanne GerberInstitute of Human Genetics, University Medical Center of the Johannes Gutenberg University, Mainz, Germany.ORCID 0000-0001-9513-0729
Edward A LemkeBiocenter, Johannes Gutenberg University, Mainz, Germany. edlemke@uni-mainz.de.ORCID 0000-0002-0634-0503

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

RNA modifications play a pivotal role in the regulation of RNA chemistry within cells. Several technologies have been developed with the goal of using RNA modifications to regulate cellular biochemistry selectively, but achieving selective and precise modifications remains a challenge. Here, we show that by using designer organelles, we can modify mRNA with pseudouridine in a highly selective and guide-RNA-dependent manner. We use designer organelles inspired by concepts of phase separation, a central tenet in developing artificial membraneless organelles in living mammalian cells. In addition, we use circular guide RNAs to markedly enhance the effectiveness of targeted pseudouridinylation. Our studies introduce spatial engineering through optimized RNA editing organelles (OREO) as a complementary tool for targeted RNA modification, providing new avenues to enhance RNA modification specificity.

Indexed as

OrganellesPseudouridineRNA EditingRNA, Guide, CRISPR-Cas SystemsRNA, MessengerHEK293 CellsHeLa CellsHumansRNARNA, CircularPseudouridineRNARNA, CircularRNA, Guide, CRISPR-Cas SystemsRNA, Messenger

Identifiers

PMID39448590
PMCPMC11502668

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.